Julia Lai-Kwon: Co-Design of an Electronic System for Monitoring Immunotherapy Toxicities
Julia Lai-Kwon shared on X:
“Co-designing digital tools like ePRO systems is important for adoption and sustainability, but there are few detailed examples available.
We co-designed an ePRO system for immunotherapy with patients, caregivers, clinicians and IT.”
Authors: Julia Lai‑Kwon, Claudia Rutherford, Stephanie Best, Thai Ly, Iris Zhang, Catherine Devereux, Dishan Herath, Kate Burbury, Michael Jefford
Dr. Julia Lai-Kwon is a Medical Oncologist and PhD candidate at the Peter MacCallum Cancer Centre. Her clinical interests encompass melanoma and other cutaneous malignancies. Dr. Lai-Kwon specializes in quality of life research, survivorship, and patient-reported outcomes, contributing to a deeper understanding of the patient experience and improving treatment approaches.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023